OBIO Innovation Agenda Leader

OBIO News
Written By Guest User

OBIO Innovation Agenda Leader

On July 21st, Gail Garland, CEO of OBIO attended the  Federal Government's Global Science Excellence Roundtable, part of the Inclusive Innovation Agenda Strategy held in Ottawa.

The session was hosted by Tyler Wish, co-founder and CEO of Sequence Bio and included  22 experts from across Canada who shared ideas  on how Canada can cultivate a spirit of innovation. The focus of the session was a discussion on how we can better leverage Canada’s global science excellence to build and sustain a powerful biotech innovation ecosystem.

The ideas generated during the session will be consolidated and presented to Minister Navdeep Bains for consideration as part of the Inclusive Innovation Agenda report.

For the full report, click here

For the Innovation Submission page, click here

Enjoy a Gallery of the Event Below!

Guest User
Previous

CAAP Company: KA Imaging Receives $1M to develop low-cost lung screening
Next

CAAP Company: iTP Biomedica Launches BladderPredict, A State-Of-The-Art Diagnostic To Manage Early Stage Bladder Cancer